CGAS and chronic kidney disease: The uraemic milieu present in CKD is associated with increases in mtROS production, which can have deleterious effects on cardiomyocytes through the release of mtDNA and subsequent activation of the cGAS-STING-NFκB pathway (Fig. 4) [42, 60].